June 12, 2019 / 5:36 AM / 2 months ago

BRIEF-Novartis Says Cosentyx Shows Efficacy In Key Manifestations Of Psoriatic Arthritis

June 12 (Reuters) - Novartis AG:

* NOVARTIS COSENTYX® FIRST TO SHOW EFFICACY IN ALL KEY MANIFESTATIONS OF PSORIATIC ARTHRITIS

* DATA SHOWS EFFICACY AND SAFETY OF A BIOLOGIC IN MANAGEMENT OF AXIAL MANIFESTATIONS OF PSORIATIC ARTHRITIS

* 66.3% OF PATIENTS TREATED WITH SECUKINUMAB 150 MG ACHIEVED RAPID AND SIGNIFICANT IMPROVEMENTS IN SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS WITH AXIAL MANIFESTATIONS AT WEEK 12 Source text for Eikon: Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below